hydroxychloroquine and cosyntropin

hydroxychloroquine has been researched along with cosyntropin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Ben-Chetrit, E; Ehrenfeld, M; Eliakim, M; Naparstek, Y	1
Filippa, MG; Panopoulos, S; Sfikakis, PP; Spanos, E; Spanos, G; Tektonidou, MG; Yavropoulou, MP	1

Trials

1 trial(s) available for hydroxychloroquine and cosyntropin

Article	Year
Short course of synacthen therapy as an adjunct in the management of rheumatoid arthritis. Clinical rheumatology, 1985, Volume: 4, Issue:2 Topics: Adrenocorticotropic Hormone; Adult; Aged; Arthritis, Rheumatoid; Aurothioglucose; Blood Sedimentation; Clinical Trials as Topic; Cosyntropin; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Injections, Intramuscular; Male; Middle Aged; Penicillamine; Retrospective Studies; Time Factors	1985

Article

Year

Short course of synacthen therapy as an adjunct in the management of rheumatoid arthritis.

Clinical rheumatology, 1985, Volume: 4, Issue:2

Topics: Adrenocorticotropic Hormone; Adult; Aged; Arthritis, Rheumatoid; Aurothioglucose; Blood Sedimentation; Clinical Trials as Topic; Cosyntropin; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Injections, Intramuscular; Male; Middle Aged; Penicillamine; Retrospective Studies; Time Factors

1985

Other Studies

1 other study(ies) available for hydroxychloroquine and cosyntropin

Article	Year
Impaired adrenal cortex reserve in patients with rheumatic and musculoskeletal diseases who relapse upon tapering of low glucocorticoid dose. Clinical and experimental rheumatology, 2022, Volume: 40, Issue:9 Topics: Adrenal Cortex; Adrenal Cortex Hormones; Adrenal Insufficiency; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Chronic Disease; Cosyntropin; Glucocorticoids; Humans; Hydrocortisone; Hydroxychloroquine; Leflunomide; Methotrexate; Prednisolone; Recurrence; Tumor Necrosis Factor Inhibitors	2022

Article

Year

Impaired adrenal cortex reserve in patients with rheumatic and musculoskeletal diseases who relapse upon tapering of low glucocorticoid dose.

Clinical and experimental rheumatology, 2022, Volume: 40, Issue:9

Topics: Adrenal Cortex; Adrenal Cortex Hormones; Adrenal Insufficiency; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Chronic Disease; Cosyntropin; Glucocorticoids; Humans; Hydrocortisone; Hydroxychloroquine; Leflunomide; Methotrexate; Prednisolone; Recurrence; Tumor Necrosis Factor Inhibitors

2022